Product
Mometasone furoate/Formoterol
1 clinical trial
1 indication
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
A Randomized, 26-Week, Placebo-Controlled Efficacy and Safety Study With a 26-Week Long-Term Safety Extension, of High- and Medium-Dose Inhaled Mometasone Furoate/Formoterol Fixed-Dose Combination Formulation Compared With Formoterol and High-Dose Inhaled Mometasone Furoate Monotherapy in Subjects With Moderate to Severe COPDStatus: Completed, Estimated PCD: 2010-07-01